Administration of 31 Units of Regular Insulin Over 4 Hours
For transitioning from intravenous to subcutaneous insulin after receiving 31 units over 4 hours (approximately 7.75 units/hour), administer half the total IV dose (approximately 15-16 units) as long-acting basal insulin immediately upon stopping the IV infusion, with the remaining half divided as rapid-acting insulin doses with meals. 1
Transition Protocol from IV to Subcutaneous Insulin
Timing and Prerequisites
- Ensure blood glucose stability below 180 mg/dL (10 mmol/L) for at least several hours before transitioning 1
- Stop IV insulin only when the hourly infusion rate is ≤0.5 units/hour; if the rate is ≥5 units/hour, this indicates major insulin resistance and the IV should remain in place 1
- Resume oral feeding before making the transition to subcutaneous insulin 1
Dose Calculation Based on 31 Units Over 4 Hours
Standard approach (50/50 split):
- Basal insulin: 15-16 units of long-acting insulin (detemir, glargine, or degludec) given immediately after stopping IV insulin 1
- Prandial insulin: Remaining 15-16 units divided among meals as rapid-acting insulin (aspart, lispro, or glulisine) 1
Alternative approach (80/20 split):
- Some protocols recommend 80% of the IV dose (approximately 25 units) as basal insulin with rapid-acting insulin added at the first meal 1
- This approach may be preferred when insulin requirements are high or insulin resistance is present 1
Practical Administration Steps
For basal insulin:
- Inject immediately after discontinuing the IV insulin infusion to prevent rebound hyperglycemia 1
- Optimal timing is 20:00 hours (8 PM); if transitioning earlier, adjust the dose proportionally and give a second injection at 20:00 hours 1
For prandial insulin:
- Administer rapid-acting insulin before each meal, adjusting doses based on carbohydrate content 1
- Initial prandial doses: Divide the remaining insulin equally among three meals (approximately 5 units per meal if using 50/50 split) 1
- Reduce prandial dose by 50% if the meal is light or carbohydrate intake is minimal 1
Monitoring and Safety Considerations
Hypoglycemia Prevention
- Monitor blood glucose every 2-4 hours initially after transition 1
- Treat hypoglycemia (<70 mg/dL) immediately by stopping insulin and administering 10-20 grams of IV dextrose (50% solution), titrated to avoid overcorrection 1
- For mild hypoglycemia (70-100 mg/dL with symptoms), administer 15-20 grams of oral glucose 1
- Recheck glucose 15 minutes after treatment and repeat if needed 1
Dose Adjustments
- If hypoglycemia occurs without clear cause, reduce the corresponding insulin dose by 10-20% 1
- For persistent hyperglycemia (>180 mg/dL), add supplemental rapid-acting insulin in 2-4 unit increments 1
- Titrate basal insulin by 2 units every 3 days to reach fasting glucose goals without hypoglycemia 1
Common Pitfalls to Avoid
- Never stop IV insulin without immediately administering subcutaneous basal insulin, as this creates a dangerous gap in insulin coverage leading to rapid hyperglycemia 1
- Do not use sliding scale insulin alone in patients previously requiring continuous IV insulin, as this approach is associated with poor glycemic control and increased complications 1
- Avoid transitioning if the IV insulin rate exceeds 3 units/hour, as this indicates high risk for postoperative complications and inadequate subcutaneous insulin absorption 1
- Do not underdose glucose when giving insulin; administer at least 50 grams of glucose with 10 units of insulin to prevent hypoglycemia 2